Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

Acquisition

11 May 2006 07:02

Ascribe plc11 May 2006 Ascribe plc ("Ascribe" or "the Group") Ascribe acquires health division ("Jade Health") of Jade Software Corporation ("Jade") for up to £3.38 million. Strategic partnership includes purchase of IP, customer contracts & goodwill Bolton, UK (May 11th 2006) - Ascribe (AIM:ASP), the health IT Group, announcestoday an important strategic move and expansion of its offering in the mentalhealth and Australasian markets with the acquisition of Jade Health, and astrategic commitment with Jade Software Corporation to ensure the long-termapplication development and maintenance of support contracts. Jade Healthprovides IT solutions to 24 hospitals and health service organisations in NewZealand, Australia and the UK. Under the terms of the agreement, Ascribe's subsidiary Protechnic Exeter Ltd hasacquired the Jade Health business for a total consideration of £3.38 millionplus an additional sum in respect of the apportioned current assets andliabilities at the date of completion. The initial consideration of £2.73million is to be satisfied by £1.5m in cash and £1.23m by the issue of 3,804,516new ordinary shares in Ascribe plc. In addition, a deferred consideration of upto £0.65m is payable, approximately 14 months after completion, subject to thebusiness achieving certain sales and profit targets. Jade will continue tosupport the business through long-term application support and developmentcontracts to ensure not only an effective transition of ownership but alsoAscribe's on-going access to skills and technology. In the year ended 31 December 2005, Jade Health recorded a profit before tax ofapproximately £0.3m on sales of approximately £2.3m. The value of the net assetsbeing acquired is estimated at approximately £0.1m. The business being acquiredhas offices in Melbourne and Sydney. The Board of Ascribe expects that thisacquisition will be earnings enhancing during the first year. In line with this announcement, Ascribe has recruited Bryn Evans as ChiefExecutive Officer of its Asia Pacific region. Bryn has over 15 years experiencein managing and providing consulting services for information systems in the UKand Australian health sectors. Bryn will be based in Sydney, where for a numberof years he was CIO of South Eastern Sydney Area Health Service. In the early90s he was also Director of Finance and Information Systems at a large NHShospital in UK. As an independent consultant Bryn has undertaken numerous majorIT projects for health services in different states of Australia, and in theMiddle East. These have comprised consultancies for private sector and publichealth service providers, and government departments in NSW, Victoria,Queensland, and the Commonwealth Government of Australia, and also in NewZealand. Ascribe has today applied to AIM for admission of the 3,804,516 initialconsideration shares, which is expected to become effective on Tuesday 16 May2006. Commenting, Stephen Critchlow, Executive Chairman of Ascribe plc, said: "Expanding Ascribe's customer base internationally is a central part of theGroup's strategy. Acquiring Jade Health significantly increases the criticalmass of the Group in the Australasian market where Ascribe already provideshospital pharmacy software solutions to four of the eight Australianjurisdictions and to 20% of the New Zealand public hospital market. JadeHealth's market leading position and brand recognition creates an excitingopportunity for Ascribe to leverage its expanded portfolio of health solutionsto the Australasian markets." Contacts: Stephen Critchlow, Executive ChairmanTel: +44 (0) 161 280 8080Email stephen.critchlow@ascribe.com Jeremy Lee, Finance DirectorTel: +44 (0) 161 280 8080Email jeremy.lee@ascribe.com Ginny Pulbrook/ Justin Griffiths, Citigate Dewe RogersonTel: +44 (0) 20 7638 9671 Notes to Editors About Ascribe plc Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to theinternational healthcare market. The Group provides solutions to Emergency andMinor Injuries units, Mental Health and Social Care units, Hospitals requiringpatient administration systems (PAS) and medical equipment management, Hospitaland Retail Pharmacies, and General Practice surgeries. Ascribe plc was floated on AIM in 2004, and currently employs 170 personnelthough its five operating companies in the UK, Hong Kong, Malaysia, Australiaand New Zealand.For more information, please visit http://www.ascribe.com About Jade Software Corporation Established in 1978, Jade Software Corporation is an information technologyresearch and development organisation, with more than 25 years' experiencesupplying enterprise scale software solutions to large businesses and governmentorganisations. The company produces; JADE - an integrated computing platform,products for the healthcare, higher education, HR and payroll, ports andshipping sectors, and also provides custom development services and systemsmanagement. A network of distributors and channel partners sells the company'sproducts and services to companies throughout Asia-Pacific, Europe and NorthAmerica. A privately owned New Zealand company, Jade employs around 250 people throughoutNew Zealand, Australia, the United States and the United Kingdom. The company'sManaging Director is Dr Rod Carr. For more information visit: www.jadeworld.com (c) Ascribe 2006. All rights reserved. Ascribe is a registered trademark ofAscribe plc. All other trademarks remain the property of their respectivecompanies and rights holders. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20072:19 pmRNSHolding(s) in Company
30th Apr 20073:12 pmRNSHolding(s) in Company
27th Apr 20073:09 pmRNSHolding(s) in Company
23rd Mar 20075:05 pmRNSHolding(s) in Company
21st Mar 20077:02 amRNSInterim Results
16th Mar 20075:03 pmRNSHolding(s) in Company
9th Mar 20072:26 pmRNSHolding(s) in Company
9th Mar 20078:43 amRNSHolding(s) in Company
8th Mar 20074:16 pmRNSHolding(s) in Company
6th Mar 20077:02 amRNSNotice of Results
13th Feb 200710:39 amRNSExercise of options
9th Feb 20079:47 amRNSHolding(s) in Company
6th Feb 20071:21 pmRNSDirectorate Change
16th Jan 20071:24 pmRNSHolding(s) in Company
10th Jan 20077:00 amRNSTrading Statement
5th Jan 20075:21 pmRNSIssue of Equity
5th Jan 20074:53 pmRNSHolding(s) in Company
29th Dec 200611:06 amRNSHolding(s) in Company
22nd Dec 200612:47 pmRNSHolding(s) in Company
22nd Dec 200612:44 pmRNSDirector/PDMR Shareholding
20th Dec 200611:36 amRNSIssue of Equity
15th Dec 20062:15 pmRNSTotal Voting Rights
28th Nov 20065:44 pmRNSHolding(s) in Company
23rd Nov 20062:46 pmRNSHolding(s) in Company
21st Nov 200611:37 amRNSHolding(s) in Company
1st Nov 20061:04 pmRNSAGM Statement
30th Oct 20063:30 pmRNSHolding(s) in Company
20th Oct 20065:05 pmRNSHolding(s) in Company
6th Oct 20061:39 pmRNSDirector/PDMR Shareholding
21st Sep 20061:34 pmRNSHolding(s) in Company
19th Sep 20067:03 amRNSAppointment of COO
15th Sep 20065:07 pmRNSDirector/PDMR Shareholding
12th Sep 20067:02 amRNSFinal Results
1st Sep 200611:45 amRNSNotice of Results
21st Aug 20067:00 amRNSChange of Adviser
5th Jul 20065:55 pmRNSHolding(s) in Company
30th Jun 20067:03 amRNSAcquisition
29th Jun 20064:24 pmRNSHolding(s) in Company
16th Jun 20065:22 pmRNSHolding(s) in Company
13th Jun 20062:50 pmRNSDirector/PDMR Shareholding
6th Jun 20064:34 pmRNSDirector/PDMR Shareholding
22nd May 20065:02 pmRNSHolding(s) in Company
11th May 20067:02 amRNSAcquisition
5th May 20067:00 amRNSUpdate on Contract Wins
15th Mar 20067:03 amRNSInterim Results
15th Mar 20067:01 amRNSAcquisition
23rd Feb 20068:12 amRNSHolding(s) in Company
21st Feb 200610:47 amRNSHolding(s) in Company
21st Feb 20069:06 amRNSHolding(s) in Company
7th Feb 20064:28 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.